US-LACRN selects Agilent gene expression microarrays for major breast cancer study

[News]

Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations.

More... (http://www.news-medical.net/news/20110421/US-LACRN-selects-Agilent-gene-expression-microarrays-for-major-breast-cancer-study.aspx)